Theodore S. Kapellos
- Immunology top 5%
- Immune cells in cancer 7
- IL-33, ST2, and ILC Pathways 2
- Neurology top 10%
- Pharmacology top 10%
- Cannabis and Cannabinoid Research 3
-
- Neonatal Respiratory Health Research 5
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
- Respiratory Support and Mechanisms 2
-
- Sleep and Wakefulness Research 3
-
- Epigenetics and DNA Methylation 2
- Co-authors
- Joachim L. SchultzeAsif IqbalEmily HinkleyLorenzo BonaguroIoanna D. GemündAdem SaglamNico ReuschDavid R. Greaves
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Theodore S. Kapellos
16 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Immunology 564
- Neurology 101
- Biological Psychiatry 28
- Pharmacology 91
- Pulmonary and Respiratory Medicine 157
Countries citing papers authored by Theodore S. Kapellos
This map shows the geographic impact of Theodore S. Kapellos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodore S. Kapellos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodore S. Kapellos more than expected).
Fields of papers citing papers by Theodore S. Kapellos
This network shows the impact of papers produced by Theodore S. Kapellos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodore S. Kapellos. The network helps show where Theodore S. Kapellos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Theodore S. Kapellos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 34 | |
| 8 | Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseasesbreakdown → | 2019 | 556 |
| 9 | 2019 | 23 | |
| 10 | 2019 | 45 | |
| 11 | 2018 | 61 | |
| 12 | 2017 | 18 | |
| 13 | 2017 | 20 | |
| 14 | 2016 | 107 | |
| 15 | 2016 | 85 | |
| 16 | 2015 | 28 | |
| 17 | 2014 | 85 | |
| 18 | 2013 | 31 |
About Theodore S. Kapellos
Theodore S. Kapellos is a scholar working on Immunology, Biological Psychiatry and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immune cells in cancer (7 papers), Neonatal Respiratory Health Research (5 papers), Cannabis and Cannabinoid Research (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Sleep and Wakefulness Research (3 papers), Epigenetics and DNA Methylation (2 papers), IL-33, ST2, and ILC Pathways (2 papers) and Respiratory Support and Mechanisms (2 papers). The work is most often cited by research in Immunology (564 citations), Neurology (101 citations) and Biological Psychiatry (28 citations). Theodore S. Kapellos has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Joachim L. Schultze, Asif Iqbal, Emily Hinkley, Lorenzo Bonaguro, Ioanna D. Gemünd, Adem Saglam, Nico Reusch, David R. Greaves, Lewis Taylor and Heyne Lee. Their work appears in journals such as Blood, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.